Cancer researchers have a multitude of tools to study tumors. Histological staining uses dyes to make different kinds of ...

The FDA approved pembrolizumab (Keytruda) for patients with PD-L1-positive resectable locally advanced head and neck squamous ...

Smoking, alcohol consumption and betel nut chewing are some of the lifestyle factors that have been linked to head and neck ...

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...

Merck & Co.’s Keytruda has become the first immunotherapy approved by the FDA to be used around surgery to treat resectable ...

A 56-year-old American man was diagnosed with stage 4 head and neck cancer after noticing a weird, painless boil on his ...

Reduce your other risk factors. Tobacco and alcohol use are some of the strongest lifestyle risk factors for head and neck cancer. In a recent study, tobacco use increased the risk of developing ...

MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...

Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in ...

The KEYNOTE-689 study showed pembrolizumab with standard of care significantly improved outcomes for resectable HNSCC, ...

Keytruda was approved for locally advanced head and neck cancer before and after surgery, showing improved event-free ...

Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...